Cullinan Therapeutics Inc (CGEM)

Cash & Short-Term Investments

$334.54M

Quarterly · Period ending: · USD

CGEM logo

CGEM Cash & Short-Term Investments

Latest reported$334.54M
CGEM Quarterly Cash & Short-Term Investments ($33.83M → $334.54M)
High-resolution chart · PNG

CGEM cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cullinan Therapeutics Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
334,538,000
351,885,000
377,896,000
332,596,000
265,482,000
303,827,000
398,977,000
578,078,000
662,495,000
433,011,000
467,067,000
466,430,000
491,798,000
390,700,000
467,292,000
575,951,000
610,995,000
314,854,000
290,466,000
321,044,000
336,705,000
440,874,000
210,206,000
219,592,000
102,973,000
98,630,000
98,630,000
33,832,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.